CH640850A5 - Nitrofurylvinylthiazol-n-oxid-verbindungen als antitumormittel. - Google Patents

Nitrofurylvinylthiazol-n-oxid-verbindungen als antitumormittel. Download PDF

Info

Publication number
CH640850A5
CH640850A5 CH454979A CH454979A CH640850A5 CH 640850 A5 CH640850 A5 CH 640850A5 CH 454979 A CH454979 A CH 454979A CH 454979 A CH454979 A CH 454979A CH 640850 A5 CH640850 A5 CH 640850A5
Authority
CH
Switzerland
Prior art keywords
compounds
compound
animals
rats
connection
Prior art date
Application number
CH454979A
Other languages
German (de)
English (en)
Inventor
Satoru Enomoto
Daisaku Immaru
Yoshiaki Osaka
Takao Kawasaki
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of CH640850A5 publication Critical patent/CH640850A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH454979A 1978-05-19 1979-05-16 Nitrofurylvinylthiazol-n-oxid-verbindungen als antitumormittel. CH640850A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5975978A JPS54151134A (en) 1978-05-19 1978-05-19 Antitumorigenic agent

Publications (1)

Publication Number Publication Date
CH640850A5 true CH640850A5 (de) 1984-01-31

Family

ID=13122504

Family Applications (1)

Application Number Title Priority Date Filing Date
CH454979A CH640850A5 (de) 1978-05-19 1979-05-16 Nitrofurylvinylthiazol-n-oxid-verbindungen als antitumormittel.

Country Status (6)

Country Link
JP (1) JPS54151134A (en:Method)
CH (1) CH640850A5 (en:Method)
DE (1) DE2920247C2 (en:Method)
FR (1) FR2426052A1 (en:Method)
GB (1) GB2021111B (en:Method)
IT (1) IT1114243B (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0413498U (en:Method) * 1990-05-24 1992-02-03
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
ES2384208T3 (es) 2001-11-01 2012-07-02 Spectrum Pharmaceuticals, Inc. Composiciones medicinales para el tratatamiento intravesical del cáncer de vejiga.
CA2646222C (en) * 2006-03-16 2016-07-05 Women And Infants Hospital Of Rhode Island, Inc. Nitrofuran compounds for the treatment of cancer and angiogenesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545606A1 (de) * 1965-07-29 1969-08-07 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
JPS5239033B1 (en:Method) * 1971-05-04 1977-10-03
JPS5239033A (en) * 1975-09-22 1977-03-26 Meidensha Electric Mfg Co Ltd An engine controlling device
GB2079568A (en) * 1980-07-02 1982-01-20 Hewlett Packard Co Data compression apparatus and method
JPS5742662A (en) * 1980-08-29 1982-03-10 Chugai Pharmaceut Co Ltd Benzoic acid amide derivative

Also Published As

Publication number Publication date
FR2426052B1 (en:Method) 1983-04-08
GB2021111A (en) 1979-11-28
IT7922723A0 (it) 1979-05-16
GB2021111B (en) 1982-11-03
JPS54151134A (en) 1979-11-28
FR2426052A1 (fr) 1979-12-14
DE2920247A1 (de) 1979-11-22
JPS6136493B2 (en:Method) 1986-08-19
IT1114243B (it) 1986-01-27
DE2920247C2 (de) 1985-09-19

Similar Documents

Publication Publication Date Title
DE69927125T2 (de) Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels
EP0240829A2 (de) Cancerostatisches Mittel
CH647534A5 (de) Cyclodextrin-kamillen-inklusionskomplexe, verfahren zur herstellung der komplexe und die komplexe enthaltenden praeparate.
DE2710327B2 (de) Verwendung von Benzaldehyd
DE2921327C3 (de) Arzneimittel zur Behandlung der Hyperglykämie, Hyperlipämie, Hypertension, von inflammatorischen Erkrankungen, Schmerzen, Pyrexie und Tumoren
CH640850A5 (de) Nitrofurylvinylthiazol-n-oxid-verbindungen als antitumormittel.
Rimington et al. Studies upon the photosensitisation of animals in South Africa X: the icterogenic factor in geeldikkop: isolation of active principles from Lippia rehmanni Pears
DE2914005C2 (de) Arzneimittel zur Behandlung von Hyperglykämie, Hyperlipämie, Hypertension, inflammatorischen Erkrankungen, Schmerzen und Pyrexie durch Erregung des Zentralnervensystems und von Tumoren
DE2349538C2 (de) Arzneimittel zur Behandlung von Lebererkrankungen
CH670047A5 (en:Method)
CH644018A5 (de) Pharmazeutisches mittel zur prostaglandinregulierung.
DE2609533C3 (de) Verfahren zur Extraktion von Wirkstoffen, insbesondere von Heterosidestern der Kaffeesäure, sowie diese Verbindungen enthaltende Arzneimittel
DE3026053C2 (de) 2-substituierte-4-Thiazolidone
CH640851A5 (de) Nitrofurylvinylverbindungen als antitumormittel.
KR101323769B1 (ko) 정제봉독과 비텍신을 유효성분으로 포함하는 동물용 기능성 천연 항생제 조성물
AT388916B (de) Verfahren zur herstellung von neuen phenylpropargylaminderivaten und deren saeureadditionssalzen
DE2707821A1 (de) Verfahren und mittel zum abtoeten von insekten
DE2347220B2 (de) L-cystin-bis- eckige klammer auf 2,2-bis-(2-chloraethyl)-hydrazid eckige klammer zu -dihydrobromid, verfahren zu seiner herstellung und dieses enthaltende arzneimittel
DE2047049B2 (de) Calciumsalz der 6-(N-Acetylamino)hexansäure, Verfahren zu seiner Herstellung und Arzneimittel mit einem GeKaIt an diesem Salz
DE3038327A1 (de) Derivat der p-aminobenzoesaeure, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzung
DE3504412A1 (de) Neue phenylpropargylaminderivate
DE1807636C3 (de) Abführmittel
DE3016616A1 (de) Verfahren zur herstellung von und pharmazeutische praeparate mit 2-(6-methoxy- 2-naphthyl)-1-propanol-estern
DE69631515T2 (de) Aus "Asphalathus Linearis" extrahiertes Antivirales- und Antikrebs-Mittel
El‐Sherif et al. Effect of adult diet and mating on egg laying capacity and longevity of potato tuber moth, Phthorimaea operculella Zeller

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased